New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry ...
The trial clearance for Shanghai-based Unixell is another step forward for the rapidly advancing Chinese biotech ecosystem, ...
Sydney hedge fund Regal Partners Ltd. was dealt a fresh blow after Immutep Ltd., an Australian biotech company it backs, ...
Biotech and drug-innovation themes continue to dominate markets—from AI-driven drug discovery to blockbuster obesity treatments—and a new ETF filing suggests asset managers want a piece of that ...
Prasad contributed to an uncertain regulatory climate for gene therapy makers focused on rare conditions. Shares of many ...
4d
Forget AI Stocks: This Potentially Disruptive Biotech Could Soar By 181%, According to Wall Street
Some artificial intelligence (AI)-focused companies have delivered exceptional returns over the past few years, but some ...
The Company’s presence at ATTD follows compelling clinical performance data from its latest CGM technology developments, which formed the basis for Trinity Biotech’s decision to advance the program ...
Vinay Prasad, an official for the Food and Drug Administration, is reportedly stepping down, which is welcome news for ...
Keeping America’s lead in biotech depends on fixing what's broken about the policy status quo — and not breaking what works, ...
Everyone should save money for retirement, since programs such as Social Security aren't meant to replace workers' entire ...
Venture capital firm Portal Innovations is planning to open a 30,000-square-foot science incubator in Salt Lake City while ...
Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results